List view / Grid view

R&D

 

Type 2 diabetes mellitus treatment market value will reach $39b by 2021

23 July 2015 | By Victoria White

The global market for type 2 diabetes mellitus therapeutics will rise in value from $23.5 billion in 2014 to an estimated $39 billion by 2021, driven primarily by rising disease prevalence and the continued uptake of recently approved and emerging branded treatments, according to business intelligence provider GBI Research.

Sanofi announces new Global Business Unit structure

15 July 2015 | By Victoria White

Sanofi plans to evolve its business with the creation of five Global Business Units: General Medicines & Emerging Markets, Specialty Care, Diabetes & Cardiovascular, Sanofi Pasteur and Merial.

Send this to a friend